The Epstein-Barr virus — a well-established risk factor for MS — is able to alter the movements of immune cells, a new study ...

Scientists at St. Jude Children’s Research Hospital and their colleagues studied immune responses to mild, moderate and ...

Many people are infected with the Epstein-Barr virus (EBV), and most are unaware of it. However, EBV can sometimes cause ...

What happens when the dengue virus enters the body? What kind of immunity cells does it encounter? What does the body's ...

Dr Belinda Kaskow explores the benefits of investigating the early stages of immune dysregulation in MS to enhance prevention ...

Stem cells from donated placentas appear safe and may help ease secondary progressive MS, a small open-label Phase 1 clinical ...

Infants hospitalized with severe COVID-19 have significantly different immune responses than adults or older children. The ...

Biomedical engineers at Georgia Tech created a treatment that could one day unlock a universal strategy for treating some of ...

Early results from a clinical trial suggest that while denosumab does not directly reduce the proliferation of breast cancer ...